Once again, Endocrine News is devoting an issue to the obesity epidemic, but this year things don’t look as dire as they have in past years. Yes, overweight and obesity is still running rampant around the world.
That’s the bad news. The good news is that with the help of the spate of new pharmaceuticals, things are definitely getting better.
When the Endocrine Society held a science writers conference dedicated to the current landscape and future horizons of GLP-1 therapies, Endocrine News Senior Editor Derek Bagley was in attendance and wrote about the presentations in “ Moving Forward: The Future of GLP-1 Therapies .” He caught up with the two experts who spoke at the conference — Priya Jaisinghani, MD, DABOM, and Mehmet Furkan Burak, MD — to learn what’s next for these medications and what they mean for people with obesity. According to Jaisinghani, a clinical assistant professor from NYU Langone in New York, these medications do much more than simply improve the number on the scale.
Endocrine News published a clinical update in Research Highlights on 30 Mar 2026.
The item focuses on Battling the Bulge: The War on Obesity.
Review the original article for the full source wording and details.